Overexpression of Apolipoprotein E3 in Transgenic Rabbits Causes Combined Hyperlipidemia by Stimulating Hepatic VLDL Production and Impairing VLDL Lipolysis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (39)
The Metabolic and Molecular Bases of Inherited Disease
1995 • 12,086 citations
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
1988 • 3,984 citations
The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observations
1972 • 1,831 citations
Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
1973 • 1,457 citations
Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E
1999 • 672 citations
Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
1992 • 458 citations
Apoproteins B and A-I and coronary artery disease in humans.
1984 • 289 citations
Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia
1980 • 275 citations
Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins
1993 • 272 citations
Kinetic bases of the primar hperlipidaemias: studies of apolipoprotein B turnover in geneticall defined subjects
1980 • 251 citations
Studies on the assembly of apolipoprotein B-100- and B-48-containing very low density lipoproteins in McA-RH7777 cells.
1994 • 218 citations
Familial Combined Hyperlipidemia Workshop
1989 • 215 citations
Overexpression and Accumulation of Apolipoprotein E as a Cause of Hypertriglyceridemia
1998 • 189 citations
Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia.
1993 • 178 citations
Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes.
1997 • 163 citations
Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections
1990 • 150 citations
Apolipoprotein B is structurally and metabolically heterogeneous in the rat.
1981 • 149 citations
The role of apolipoprotein E genetic variants in lipoprotein disorders
1992 • 148 citations
Apolipoprotein E Effectively Inhibits Lipoprotein Lipase-mediated Lipolysis of Chylomicron-like Triglyceride-rich Lipid Emulsions and
1996 • 143 citations
Chylomicron metabolism
1989 • 139 citations
Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
1994 • 130 citations
Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans.
1995 • 108 citations
Plasma Concentration of Apolipoprotein E in Intermediate-Sized Remnant-Like Lipoproteins in Normolipidemic and Hyperlipidemic Subjects
1996 • 94 citations
Amino acid sequence of human plasma apolipoprotein C-II from normal and hyperlipoproteinemic subjects.
1984 • 83 citations
Carboxyl-terminal truncation impairs lipid recruitment by apolipoprotein B100 but does not affect secretion of the truncated apolipoprotein B-containing lipoproteins.
1994 • 83 citations
Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma.
1998 • 82 citations
Apolipoprotein E2 Reduces the Low Density Lipoprotein Level in Transgenic Mice by Impairing Lipoprotein Lipase-mediated Lipolysis of Triglyceride-rich Lipoproteins
1998 • 81 citations
Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse.
1994 • 81 citations
Low rates of apoB secretion from HepG2 cells result from reduced delivery of newly synthesized triglyceride to a “secretion-coupled” pool.
1996 • 79 citations
Role of Heparan Sulfate Proteoglycans and the LDL Receptor‐Related Protein in Remnant Lipoprotein Metabolisma
1994 • 68 citations
Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort
1997 • 68 citations
Both Lipolysis and Hepatic Uptake of VLDL Are Impaired in Transgenic Mice Coexpressing Human Apolipoprotein E*3Leiden and Human Apolipoprotein C1
1996 • 59 citations
Apolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse.
1995 • 56 citations
Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner
1997 • 55 citations
Apolipoprotein E2 Transgenic Rabbits
1997 • 51 citations
Kinetics of lipolysis of very low density lipoproteins by lipoprotein lipase. Importance of particle number and noncompetitive inhibition by particles with low triglyceride content.
1994 • 46 citations
The Enhanced Association of Apolipoprotein E With Apolipoprotein B–Containing Lipoproteins in Serum-Stimulated Hepatocytes Occurs Intracellularly
1995 • 37 citations
Hypolipidemic and Hyperlipidemic Phenotypes in Transgenic Mice Expressing Human Apolipoprotein E2
1996 • 36 citations
Genetic Factors Precipitating Type III Hyperlipoproteinemia in Hypolipidemic Transgenic Mice Expressing Human Apolipoprotein E2
1997 • 29 citations